Preview

Ophthalmology in Russia

Advanced search

CLINICAL FEATURES, DIAGNOSIS, THE RESULTS OF THERAPEUTIC AND SURGICAL TREATMENT OF ACANTHAMOEBIC KERATITIS

https://doi.org/10.18008/1816-5095-2017-4-306-314

Abstract

Purpose: to describe our experience in Acanthamoeba keratitis diagnostics and treatment in the FGBNU Research Institute of eye diseases, Moscow.

Patients and Methods. We observed 24 patients (25 eyes) with the Acanthamoeba keratitis (AK). The age ranged from 18 to 47 years. All patients, except one, were contact lenses wearers. Clinical signs included superficial epithelial-stromal lesions in 8 patients (8 eyes), stromal forms of AK- in 16 patients (17 eyes), and mixed keratitis in 9 (9 eyes). We used confocal microscopy, conjunctival smearing and blood immunofluorescent analysis for HSV types I and II. 8 patients (8 eyes) underwent penetrating keratoplasty (PKP) and their corneal buttons were morphologically examined. AK treatment included 2 biguanid antiseptics — a PHMB ("Comfort-drops" — solution for contact lenses care) and 0.025% solution of a chlorhexidini bigluconati, or "Vitabact" in frequent instillations. We also used Diflucan solution 0.2% instillations — 6–8 times a day in, and Orungal or Diflucan per os (200 mg once a day). Eye drops of aminoglycozide or fluorhinolon groups were added to the treatment as well. In the cases of mixed Acanthamoeba and HSV keratitis we used anti-herpetic medications (Poludan, Acyclovir).

Results. Cysts were found with confocal microscopy in 66% examined patients, and in 75% of the corneal buttons after keratoplasty. 15 cases (60%) healed with various intensity opacities. We removed corneal epithelium in 2 patients with poor effect of the medication treatment. 8 patients (8 eyes) underwent PKP with transparent (2 patients) and a semi-transparent engraftment (2 patients), in 4 cases (4 eyes) AK recurrences had occurred, what required repeated surgery. Long persistence of Acanthamoeba cysts in the cornea after clinical recovery caused the admission of 2 antiseptic biguanids eye drops for 6–20 months in all patients. There were no recurrences in the group of patients during the observation period (range 1 to 6 years).

Conclusion. AK is an extremely dangerous cornea disease , in most cases developing with contact lenses. Effective instrumental diagnostics methods of AK are confocal microscopy and morphological examination of distant corneal discs. Often, AK combined with a herpetic and bacterial infection (mixed keratitis). AK treatment requires the active use of several antiseptic agents with amoebicidal action, mycostatic drugs, antibiotics and other drugs. Therapeutic keratoplasty, often necessary in AK, accompanied by a high risk of complications and relapses of the disease, but in 50% cases, good results were achieved.

About the Authors

Evg. A. Kasparova
Research Institute of Eye Diseases
Russian Federation

PhD, Leading Researcher of Corneal Pathology Department.

11A,B, Rossolimo St.,119021 Moscow



A. A. Kasparov
Research Institute of Eye Diseases
Russian Federation

MD, professor, Нead of Corneal Pathology Department.

11A,B, Rossolimo St.,119021 Moscow



N. R. Marchenko
Research Institute of Eye Diseases
Russian Federation

PhD, Researcher of Corneal Pathology Department.

11A,B, Rossolimo St.,119021 Moscow



A. A. Fedorov
Research Institute of Eye Diseases
Russian Federation

PhD, Head of the Department of Basic Research in Ophthalmology.

11A,B, Rossolimo St.,119021 Moscow, Russia



G. B. Egorova
Research Institute of Eye Diseases
Russian Federation

MD, chief researcher of the refractive disorders department.

11A,B, Rossolimo St.,119021 Moscow



M. V. Kobzova
Research Institute of Eye Diseases
Russian Federation

PhD, Assistant of the Ophthalmology Department.

11A,B, Rossolimo St.,119021 Moscow



T. S. Mitichkina
Research Institute of Eye Diseases
Russian Federation

PhD, Senior Research Officer.

11A,B, Rossolimo St.,119021 Moscow



References

1. Moore M, McCulley J, Kaufman H, Robin J. Radial Keratoneurltis as a Presenting Sign in Acanthamoeba keratitis. Ophthalmology. 1986;93(10):1310-1315. doi:10.1016/s0161-6420(86)33572-3.

2. Moore M, McCulley J, Newton C, Cobo L, Foulks G, O’Day D. Acanthamoeba Keratitis; a growing problem in hard and soft contact lenses wearers. Ophthalmology. 1987;94(12):1654-1661. doi: 10.1016/s0161-6420(87)33238-5.

3. Dart J, Radford C, Minassian D, Verma S, Stapleton F. Risk Factors for Microbial Keratitis with Contemporary Contact Lenses. Ophthalmology. 2008;115(10):16471654.e3.doi:10.1016/j.ophtha.2008.05.003.

4. Волков В.В., Забайкина Т. П. Каминская, Л.Ю., Астахов С.Ю., Гордеева Л.М. Акантамебный кератит (по данным литературы и собственным наблюдениям). Вестник офтальмологии. 1994;110(1):28-31. [Volkov V.V., Zabajkina T.P., Kaminskaja L.Ju. Astahov S.Ju, Gordeeva L.M. Acanthamoebic keratitis (according to the literature and own observations). [Annals of ophthalmology=Vestnik oftal’mologii. 1994;110(1): 28-31. (in Russ.)].

5. Околов И.Н., Каргальцева Н.М., Науменко В.В., Никулин С.А. Акантамеба и акантамебный кератит. Руководство для врачей под ред. Л.И.Балашевича. Санкт-Петербург. 2005:54. [Okolov I.N., Kargal’ceva N.M., Naumenko V.V., Nikulin S.A.. Acanthameba and acanthameba keratitis / Manual for doctors. ed. L.I.Balashevich — SPb 2005:54 (in Russ.)].

6. Аветисов С. Э., Гордеева Л. М., Григорян М. Б. Акантамебные поражения роговицы. Вестник офтальмологии. 2001;117(5):53-55. [Avetisov S. Je., Gordeeva L. M., Grigorjan M. B. Acanthamoebae lesions of the cornea [Annals of ophthalmology=Vestnik oftal’mologii. 2001;117(5):53-55 (in Russ.)].

7. Майчук Ю.Ф, Майчук Д.Ю. Клинические формы акантамебного кератита в свете биомикроскопии и конфокальной микроскопии. Вестник Офтальмологии. 2004;120(1):45–47. [Majchuk Ju.F, Majchuk D.Ju. Clinical forms acanthameba keratitis in light of biomicroscopy and confocal microscopy. Annals of ophthalmology=Vestnik oftal’mologii. 2004;120(1):45–47. (in Russ.)].

8. Аветисов С.Э, Каспаров А.А., Марченко Н.Р., Федоров А.А., Каспарова Евг.А., Бородина Н.В., Лосева И.Е. Акантамебный кератит — клиника, диагностика и лечение. В сб. Современные методы диагностики и лечения заболеваний роговицы и склеры. М.2007:173-178. [Avetisov S.Je, Kasparov A.A., Marchenko N.R., Fedorov A.A., Kasparova Evg.A., Borodina N.V., Loseva I.E. Acanthameba keratitis — clinical features, diagnosis and treatment. Moscow. 2007:173-178 (in Russ.)].

9. Марченко Н.Р., Каспарова Евг..А. Диагностика акантамебного кератита. Вестник офтальмологии. 2016;132(5):103-109. [Marchenko N.R., Kasparova Evg.A. Diagnostic of Acanthameba keratitis. Annals of ophthalmology=Vestnik oftal’mologii 2016;132(5): 103-109 (in Russ.)].

10. Марченко Н.Р., Каспарова Евг..А. Лечение акантамебного кератита. Вестник офтальмологии . 2016;132(5):110-116. [Marchenko N.R., Kasparova Evg.A. Treatment of Acanthameba keratitis. [Annals of ophthalmology=Vestnik oftal’mologii. 2016;132(5):110-116 (in Russ.)].

11. Lorenzo-Morales J, Martín-Navarro CM, López-Arencibia A, Arnalich-Montiel F, Piñero JE, Valladares B. Acanthamoeba keratitis: an emerging disease gathering importance worldwide? Trends in Parasitology. 2013;29(4):181–187. doi: 10.1016/j.pt.2013.01.006.

12. Lim N, Goh D, Bunce C, Xing W, Fraenkel G, Poole TR, Ficker L. Comparison of polyhexamethylene biguanide and chlorhexidine as monotherapy agents in the treatment of Acanthamoeba keratitis. American Journal of Ophthalmology. 2008;145:130–135. doi: 10.1016/j.ajo.2007.08.040.

13. Turner NA, Russell AD, Furr JR, Lloyd D. Emergence of resistance to biocides during differentiation of Acanthamoeba castellanii. Journal of Antimicrobials and Chemotherapy. 2000;46(1):27–34. doi: 10.1093/jac/46.1.27

14. Roberts CW, Henriquez FL. 2010. Drug target identification, validation, characterisation and exploitation for treatment of Acanthamoeba (species) infections. Experimental Parasitology. 2009;126,91-96. doi: 10.1016/j.exppara.2009.11.016.

15. Nguyen TH, Weisenthal RW, Florakis GJ, Reidy JJ, Gaster RN, Tom D. Penetrating keratoplasty in active Acanthamoeba keratitis. Cornea. 2010;29:1000–1004. doi: 10.1097/ICO.0b013e3181cc79a1.

16. Ficker F.A, Kirkness C, Wright P. Prognosis for keratoplasty in Acanthamoeba keratitis. Ophthalmology. 1993;100:105-110. doi:10.1016/S0161-6420(93)31707-0

17. Brooks JG Jr, Coster DJ, Badenoch PR Acanthamoeba keratitis reesolution after epithelial debridement. Cornea.1994;13:186-189.

18. Kandori M, Inoue T, Shimabukuro M, Hayashi H, Hori Y, Maeda N, Tano Y. Four cases of Acanthamoeba keratitis treated with phototherapeutic keratectomy. Cornea. 2010;29(10):1199–1202. doi: 10.1097/ICO.0b013e3181d3d674

19. Майчук Д.Ю., Чилингарян Л.Б., Кишкин Ю.И., Майчук Н.В. Хирургическое лечение акантамебного кератита методом фототерапевтической кератоэктомии. Анализ проблемы и клинический случай. Офтальмохирургия. 2011;6:51-54. Majchuk D.YU., Chilingaryan L.B., Kishkin YU.I., Majchuk N.V. Surgical treatment of Acanthamoeba keratitis with method of phototherapeutic keratectomy. Analysis of problem and clinical case. Ophtalmosurgery=Oftal’mohi rurgija . 2011;6:51-54. (in Russ.)].

20. Khan YA, Kashiwabuchi RT, Martins SA, Castro-Combs JM, Kalyani S, Stanley P, Flikier D, Behrens A. Riboflavin and ultraviolet light a therapy as an adjuvant treatment for medically refractive Acanthamoeba keratitis: report of 3 cases. Ophthalmology. 2011;118(2):324–331. doi: 10.1016/j.ophtha.2010.06.041

21. Бикбова Г. М. Зайнуллина Н. Б. Усубов Э. Л. Случай акантамебного кератита. Медицинский вестник Башкортостана 2012;7(6):93-95. Bikbova G. M. Zajnullina N. B. Usubov EH. L. Case of Acanthamoeba keratitis. Bashkortostan Medical Journal= Meditsinskiy vestnik Bashkortostana. 2012;7 (6): 93-95 (in Russ.)].

22. Abdulhalim B, Wagih MM, Gad AA, Boghdadi G, Nagy RR. Amniotic membrane graft to conjunctival flap in treatment of non-viral resistant infectious keratitis: a randomised clinical study. British Journal of Ophthalmology. 2015;99(1):59–63. doi:10.1136/bjophthalmol-2014-305224

23. Краснов М.М., Каспаров А.А., Ульянова Т.Ю., Фадеева Л.Л. «Полудан в лечении вирусных заболеваний глаза». М., 1990. Krasnov M.M., Kasparov A.A., Ul’yanova T.YU., Fadeeva L.L. Poludan in the treatment of viral diseases of the eye. Moscow, 1990 (in Russ.)].

24. Carnt N, Robaei D, Watson SL, Minassian DC, Dart JK. The Impact of Topical Corticosteroids Used in Conjunction with Antiamoebic Therapy on the Outcome of Acanthamoeba Keratitis. Ophthalmology. 2016;123(5):984-990. doi: 10.1016/j.ophtha.2016.01.020.

25. McClellan K, Howard K, Niederkorn JY, Alizadeh H. Effect of steroids on Acanthamoeba cysts and trophozoites. Investigative Ophthalmology and Visual Science. 2001;42:2885–2893.

26. Каспарова Евг.А. Гнойные язвы роговицы: клиника, диагностика, консервативное лечение. Вестник офтальмологии. 2015; 131(6):106-119. Kasparova Evg.A. Purulent corneal ulcers: clinic, diagnosis, conservative treatment. Annals of ophthalmology=Vestnik oftal’mologii. 2015;131(6):106-119 doi: 10.17116/oftalma2015131


Review

For citations:


Kasparova E.A., Kasparov A.A., Marchenko N.R., Fedorov A.A., Egorova G.B., Kobzova M.V., Mitichkina T.S. CLINICAL FEATURES, DIAGNOSIS, THE RESULTS OF THERAPEUTIC AND SURGICAL TREATMENT OF ACANTHAMOEBIC KERATITIS. Ophthalmology in Russia. 2017;14(4):306-314. (In Russ.) https://doi.org/10.18008/1816-5095-2017-4-306-314

Views: 4026


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1816-5095 (Print)
ISSN 2500-0845 (Online)